Neutra (NTRR) Stock Price, News & Analysis
Company Description
Neutra (OTC Link: NTRR) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $437.7K.
NTRR has gained 0.0% over the past year. Shares last traded at $0.0001.
For FY2023, Neutra reported revenue of $68K.
This page collects what Stock Titan holds for NTRR, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Neutra (NTRR) stock last closed at $0.0001. Over the past 12 months, the stock has gained 0.0%. At a market capitalization of $437.7K, NTRR is classified as a micro-cap stock with approximately 2.9B shares outstanding.
Latest News
Neutra has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, clinical trial. View all NTRR news →
SEC Filings
Financial Highlights
Neutra generated $68K in revenue in FY2023, retaining a 51.9% gross margin, and operating income reached -$298K (-437.8% operating margin). The company generated -$153K in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
NTRR Company Profile & Sector Positioning
Neutra (NTRR) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing NTRR often look at related companies in the same sector, including Pharmagreen Biotech Inc (PHBI), Aequus Pharmaceu (AQSZF), Gold River Prod (GRPS), Gelstat Corp (GSAC), and Vibe Growth (VIBEF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NTRR's relative position within its industry.